Jane Street’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-138,189
| Closed | -$80.1K | – | 10966 |
|
|
2024
Q3 | $80.1K | Sell |
138,189
-565,128
| -80% | -$317K | ﹤0.01% | 9066 |
|
|
2024
Q2 | $435K | Buy |
703,317
+554,787
| +374% | +$469K | ﹤0.01% | 7244 |
|
|
2024
Q1 | $382K | Sell |
148,530
-52,452
| -26% | -$128K | ﹤0.01% | 7158 |
|
|
2023
Q4 | $410K | Buy |
+200,982
| New | +$367K | ﹤0.01% | 7112 |
|
|
2023
Q3 | – | Sell |
-17,007
| Closed | -$33.2K | – | 9569 |
|
|
2023
Q2 | $33.2K | Sell |
17,007
-383,602
| -96% | -$898K | ﹤0.01% | 8290 |
|
|
2023
Q1 | $1.11M | Buy |
400,609
+331,948
| +483% | +$948K | ﹤0.01% | 4809 |
|
|
2022
Q4 | $237K | Buy |
68,661
+13,890
| +25% | +$39.7K | ﹤0.01% | 7403 |
|
|
2022
Q3 | $141K | Sell |
54,771
-26,344
| -32% | -$83.9K | ﹤0.01% | 8449 |
|
|
2022
Q2 | $196K | Sell |
81,115
-150,644
| -65% | -$396K | ﹤0.01% | 8208 |
|
|
2022
Q1 | $955K | Buy |
231,759
+175,047
| +309% | +$927K | ﹤0.01% | 6234 |
|
|
2021
Q4 | $730K | Buy |
56,712
+16,367
| +41% | +$181K | ﹤0.01% | 6558 |
|
|
2021
Q3 | $436K | Buy |
+40,345
| New | +$367K | ﹤0.01% | 7542 |
|
|
2021
Q2 | – | Sell |
-41,861
| Closed | -$395K | – | 10569 |
|
|
2021
Q1 | $395K | Buy |
+41,861
| New | +$577K | ﹤0.01% | 7232 |
|
|
2020
Q4 | – | Sell |
-11,923
| Closed | -$32K | – | 8254 |
|
|
2020
Q3 | $32K | Buy |
+11,923
| New | +$44.3K | ﹤0.01% | 6983 |
|
Other funds holding GRTS
Jane Street's GRTS Position: Q4 2024 in Review
Jane Street sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 138,189 shares — an estimated $80.1K sold.
Jane Street first reported a position in GRTS in Q3 2020 and held it in 14 quarters. The position peaked at $1.11M in Q1 2023. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.
- Jane Street reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Jane Street sold 138,189 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $80.1K.
- Jane Street first reported a position in Gritstone bio, Inc. Common Stock in Q3 2020 and held it in 14 quarters.
- Jane Street's Gritstone bio, Inc. Common Stock position peaked at $1.11M in Q1 2023.
- 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.
Based on Jane Street's 13F filing for Q4 2024, filed 14 Feb 2025.